Barrick Gold Corporation (NYSE: GOLD) is one of the world leaders in the gold mining industry, which works in 13 countries of the world, produces approximately 4.5 million ounces of gold per year and has a total reserve of about 68 million ounces..
Cryptocurrency trader Lark Davis believes, that the current correction of bitcoin does not give any reason for panic According to him, the current rollback of the bitcoin rate is relatively small, even though, that the entire increase in the BTC rate was lost this month: "So far, the bitcoin rate is only decreasing., but at the peak of the pullback, BTC was only 11,5% below the recent all-time high. Taking October as an example, then between the peak and the bottom of the bitcoin rate was 14%. The average BTC correction rate during a bull run is just over 20%. ”Davis emphasized, that in September the BTC rate fell by 25% – from the level $53 000 to $39 600, and the current corrective movement from the historical high can also lower BTC to $53 000. Based on data from the analytical company Glassnode, the trader used the UPRD metric and highlighted the level $53 000 as an important support: "The number of people moved for the last time after Bitcoin reached capitalization is higher $1 trillion coins is now 3,45 million BTC. I.e, 18,3% sentences moved at a rate higher $53 000, что свидетельствует о притоке капитала Большие объемы BTC перемещались при курсе более $53 000, which indicates bullish sentiment among many investors. I believe, that the zone is in the middle of the range $50 000 – $60 000 является ключевой областью курсовой поддержки …
Cryptocurrency analyst Nicholas Merten noted 3 cryptocurrencies, which can show rapid growth during the season of altcoins Cryptanalyst called 3 potentially very profitable cryptocurrencies He is closely watching the sector, which has the most significant potential and, according to Merten, promising first-layer protocols – the best choice for investors in this market. First on the list is the e-Radix Layer 1 protocol (EXRD), created specifically for the DeFi sector. Asset paired against BTC demonstrates exceptional dynamics: “Downward Wedge Breakout in Pair Against BTC, trading volumes increased and the rate began to rise. Each time a rollback, support was found at the previous resistance level. " 30 days EXRD rate grew by almost 500% and almost reached $0,5. Next comes the blockchain with support for smart contracts, by decentralized voting and self-funded Energi treasury (NRG). According to the analyst, the asset is ready for a breakout after a long hibernation: “Due to a significant number of fundamental factors, Energi is well positioned to rally and may even start its first major bull rally. I like assets, которые долгое время находились на заднем плане» В течение недели курс NRG вырос 29% and is near $2,28. And at the bottom of the list is the IOTA open source distributed ledger (SINCE WHEN). Merten thinks, that MIOTA is in a period of long-term accumulation and is ready for a breakout. In a week …
Cryptanalyst called 3 potentially very profitable cryptocurrencies Read more
South Korean robo-advisor Fount attracted in the last stage $33,4 million investments. The tools will be used to extend the capabilities of developing platforms using ML. The main investors were financial companies Hana Financial Investment and Nice Investment.
We talk about the emergence and development of the ETF market. Exchange Traded Funds - exchange-traded funds, who invest in certain assets or their groups. As a matter of fact, they own the underlying assets (shares, bonds, commodity futures, foreign currency, etc.) and produce papers on them.
The developer of graphics processors Nvidia reported for the third quarter of 2022 fiscal year. Here's how the key financial indicators grew compared to last year: revenue — on 50%, up to $7.1 billion; operating profit — on 91%, up to 2.7 billion; net profit — on 84%, up to 2.5 billion.
«M-video-eldorado» (MCX: MVID) — one of the leading players in the Russian retail market of household appliances and electronics. 21 In October, the company published key operating results for 9 months of 2021.
Today we have a speculative idea: take shares of american tire manufacturer Goodyear Tire & Rubber (NASDAQ: GT), to capitalize on the expected growth of orders from this company. Growth potential and validity: 14% behind 15 Months; 8% per annum during 10 years.
Heron Therapeutics (NASDAQ: HRTX) - San Diego-based biotechnology company, founded in the USA in 1983. Business is focused on helping patients, undergoing chemotherapy, and relief of postoperative pain. In the distant past, the company's shares were more expensive 1000 $ for pike, and now dropped to 10-12 $. Where the money comes from Commercial business strategy is focused on addressing the unmet needs of different groups of patients and is now engaged in research in the field of oncology and surgery.. The company has already brought several drugs to the U.S. market to relieve postoperative pain and relieve symptoms., caused by different courses of chemotherapy. Product Development Portfolio To date, Heron Therapeutics has successfully commercialized three of its products. Zynrelef. For the first time 72 hours relieves pain in adult patients, who have undergone major knee surgery. Approved by the Food and Drug Administration (FDA) 1 July 2021 and became an alternative to traditional opioids, the use of which is associated with the risk of addiction. Approved in 31 European country. Cinvanti and Sustol. Drugs for adult patients with cancer. Prevents nausea & vomiting, caused by the passage of primary and repeated courses of chemotherapy of varying degrees of aggressiveness. The company has two drugs for adults at the clinical stage of development: HTX-034 to relieve postoperative pain in the first 5-7 days and HTX-019, which prevents bouts of nausea and vomiting in patients, who have undergone surgery. For the latter, it is planned to apply for FDA approval in the fourth quarter of 2021.. Что плохого Коронавирус наносит ответный удар. Last year, the pandemic and lockdowns significantly hurt the company's business.: medical facilities were closed and patients simply could not get their appointments from doctors., prescription drug manufacturers suffered losses. Сейчас ситуация с вакцинацией и мерами профилактики …
Heron Therapeutics Review: solutions for oncology and postoperative recovery Read more
Today we have a speculative idea: take shares of the American manufacturer of automotive oils and lubricants Valvoline (NYSE: VVV), in order to earn on the growth of demand for the company's products. Growth potential and validity: 14% behind 14 months excluding dividends; 9% per annum during 10 years including dividends.